{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:58:49Z","timestamp":1762541929340},"reference-count":29,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1159\/000244265","type":"journal-article","created":{"date-parts":[[2010,5,17]],"date-time":"2010-05-17T08:17:06Z","timestamp":1274084226000},"page":"250-258","source":"Crossref","is-referenced-by-count":17,"title":["Beneficial Effects of 5-Fluorouracil and Heparin-Based Portal Infusion Chemotherapy Combined with Mitomycin C and Cisplatin after Curative Resection of Pancreatic Cancer"],"prefix":"10.1016","volume":"10","author":[{"given":"Koichi","family":"Aiura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1159\/000244265_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00000658-200301000-00011","article-title":"Prognostic factors following curative resection for pancreaticadenocarcinoma:apopulation-based, linked database analysis of 396 patients","volume":"237","author":"Lim","year":"2003","journal-title":"Ann Surg"},{"key":"10.1159\/000244265_bib2","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1159\/000244265_bib3","first-page":"267","article-title":"Adjuvant chemotherapy with gemcitabine vs","volume":"297","author":"Oettle","year":"2007","journal-title":"observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA"},{"key":"10.1159\/000244265_bib4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000051469","article-title":"Treatment strategy for pancreatic head cancer: pylorus-preserving pancreatoduodenectomy, intraoperative radiotherapy and portal catheterization","volume":"60","author":"Takahashi","year":"1999","journal-title":"Digestion"},{"key":"10.1159\/000244265_bib5","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1073\/pnas.061615598","article-title":"Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis","volume":"98","author":"Borsig","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1159\/000244265_bib6","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1016\/S0049-3848(07)70138-X","article-title":"Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects","volume":"120","author":"Stevenson","year":"2007","journal-title":"Thromb Res"},{"key":"10.1159\/000244265_bib7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.thromres.2007.06.015","article-title":"Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin","volume":"121","author":"Marchetti","year":"2008","journal-title":"Thromb Res"},{"key":"10.1159\/000244265_bib8","first-page":"3433","article-title":"Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity","volume":"59","author":"Parish","year":"1999","journal-title":"Cancer Res"},{"key":"10.1159\/000244265_bib9","first-page":"290","article-title":"Inhibition of tumor metastasis by heparanase inhibiting species of heparin","volume":"14","author":"Vlodavsky","year":"1994","journal-title":"Invasion Metastasis"},{"key":"10.1159\/000244265_bib10","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1200\/JCO.2005.03.134","article-title":"The effect of low molecular weight heparin on survival in patients with advanced malignancy","volume":"23","author":"Klerk","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1159\/000244265_bib11","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1200\/JCO.2005.03.133","article-title":"Randomized comparison of low molecular weight heparin coumarin derivates on the survival of patients with cancer and venous thromboembolism","volume":"23","author":"Lee","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1159\/000244265_bib12","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1136\/bmj.2.6098.1320","article-title":"Adjuvant liver perfusion in colorectal cancer: initial results of a clinical trial","volume":"ii","author":"Taylor","year":"1977","journal-title":"Br Med J"},{"key":"10.1159\/000244265_bib13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/01.sla.0000143300.49878.51","article-title":"Clinical significance of dihydropyrimidine dehydrogenase in adjuvant 5-fluorouracil liver perfusion chemotherapy for pancreatic cancer","volume":"240","author":"Nakayama","year":"2004","journal-title":"Ann Surg"},{"key":"10.1159\/000244265_bib14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0002-9610(05)80167-9","article-title":"Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas","volume":"168","author":"Ishikawa","year":"1994","journal-title":"Am J Surg"},{"key":"10.1159\/000244265_bib15","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1200\/JCO.2004.10.002","article-title":"Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS)","volume":"22","author":"Kakkar","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1159\/000244265_bib16","first-page":"CD006652","article-title":"Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation","volume":"18","author":"Akl","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1159\/000244265_bib17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jso.20728","article-title":"Low molecular weight heparin increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer","volume":"95","author":"Icli","year":"2007","journal-title":"J Surg Oncol"},{"key":"10.1159\/000244265_bib18","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1160\/TH07-01-0004","article-title":"Effect of low-molecular-weight heparin on survival in patients with advanced pancreatic adenocarcinoma","volume":"98","author":"Von Delius","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1159\/000244265_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00685830","article-title":"Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo","volume":"32","author":"Shirasaka","year":"1993","journal-title":"Cancer Chemothr Pharmacol"},{"key":"10.1159\/000244265_bib20","first-page":"1059","article-title":"Chemosensitivity of human pancreatic cancer cell lines serially transplanted in nude mouse","volume":"18","author":"Tomikawa","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1159\/000244265_bib21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jso.2930560408","article-title":"Synergistic antitumor activity of combination chemotherapy with mitomycin C and cisplatin against human gastric cancer xenografts in nude mice","volume":"56","author":"Saikawa","year":"1994","journal-title":"J Surg Oncol"},{"key":"10.1159\/000244265_bib22","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial","volume":"15","author":"Burris","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1159\/000244265_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jjco\/hye003","article-title":"Phase I trial of gemcitabine in patients with advanced pancreatic cancer","volume":"31","author":"Okada","year":"2001","journal-title":"Jpn J Clin Oncol"},{"key":"10.1159\/000244265_bib24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/BF00294750","article-title":"Aggressive surgery for pancreatic duct cell cancer: feasibility, validity, limitations","volume":"19","author":"Takahashi","year":"1995","journal-title":"World J Surg"},{"key":"10.1159\/000244265_bib25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.gassur.2005.09.016","article-title":"Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings","volume":"10","author":"Hishinuma","year":"2006","journal-title":"J Gastrointest Surg"},{"key":"10.1159\/000244265_bib26","first-page":"899","article-title":"Pancreatic cancer","volume":"120","author":"Kalser","year":"1985","journal-title":"Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg"},{"key":"10.1159\/000244265_bib27","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00000658-199912000-00006","article-title":"Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group","volume":"230","author":"Klinkenbijl","year":"1999","journal-title":"Ann Surg"},{"key":"10.1159\/000244265_bib28","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.ijrobp.2007.07.2346","article-title":"Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis","volume":"70","author":"Valentini","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1159\/000244265_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.mpa.0000166998.04266.88","article-title":"Factors predicting recurrence after resection of pancreatic ductal carcinoma","volume":"31","author":"Shibata","year":"2005","journal-title":"Pancreas"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390310800857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390310800857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:51:49Z","timestamp":1559112709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390310800857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":29,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1424390310800857"],"URL":"https:\/\/doi.org\/10.1159\/000244265","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}